Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Paule Chinet"'
Autor:
Valentina Orlando, Damien Drubay, Pernelle Lavaud, Laura Faivre, François Lesaunier, Remy Delva, Gwenaëlle Gravis, Frédéric Rolland, Frank Priou, Jean-Marc Ferrero, Nadine Houede, Loic Mourey, Christine Theodore, Ivan Krakowski, Jean-François Berdah, Marjorie Baciuchka, Brigitte Laguerre, Aude Fléchon, Marine Grosse-Goupil, Isabelle Cojean-Zelek, Stéphane Oudard, Jean-Luc Labourey, Paule Chinet-Charrot, Eric Legouffe, Jean-Léon Lagrange, Claude Linassier, Gaël Deplanque, Philippe Beuzeboc, Jean-Louis Davin, Anne-Laure Martin, Meryem Brihoum, Stéphane Culine, Gwénaël Le Teuff, Karim Fizazi
Publikováno v:
Clinical Genitourinary Cancer.
Autor:
Nadine Houede, Claude Linassier, Philippe Beuzeboc, Paule Chinet-Charrot, Laura Faivre, Loic Mourey, Aude Flechon, Frank Priou, Gael Deplanque, Jean-Marc Ferrero, Jean-Louis Davin, Christine Theodore, Muriel Habibian, Brigitte Laguerre, Remy Delva, Anne-Laure Martin, Ivan Krakowski, Agnès Laplanche, Karim Fizazi, Frederic Rolland, Jean-Luc Labourey, Stéphane Culine, Jean-François Berdah, Gwenaelle Gravis, François Lesaunier, Isabelle Cojean-Zelek, Eric Legouffe, Alain Ravaud, Marjorie Baciuchka, Stéphane Oudard, Jean-Léon Lagrange
Publikováno v:
Lancet Oncology
Lancet Oncology, Elsevier, 2015, 16 (7), pp.787-794. ⟨10.1016/S1470-2045(15)00011-X⟩
Lancet Oncology, 2015, 16 (7), pp.787-794. ⟨10.1016/S1470-2045(15)00011-X⟩
Lancet Oncology, Elsevier, 2015, 16 (7), pp.787-794. ⟨10.1016/S1470-2045(15)00011-X⟩
Lancet Oncology, 2015, 16 (7), pp.787-794. ⟨10.1016/S1470-2045(15)00011-X⟩
International audience; BACKGROUND:Early risk-stratified chemotherapy is a standard treatment for breast, colorectal, and lung cancers, but not for high-risk localised prostate cancer. Combined docetaxel and estramustine improves survival in patients
Autor:
Paule Chinet-Charrot, Frank Priou, Michel Henry-Amar, Nadine Houédé, Frederic Rolland, Aude Flechon, Stéphane Culine, Sabine Noal, Florence Joly, Christine Chevreau
Publikováno v:
Clinical Genitourinary Cancer. 7:E28-E33
Background There is no standard second-line chemotherapy for patients who relapse with advanced urothelial carcinoma. A GETUG phase II clinical trial was designed to evaluate the response rate and the palliative clinical benefit of weekly paclitaxel.
Autor:
Paule Chinet, Jean Pierre Basuyau, Brunelle P, Annie Chevrier, Marie Hélène Grongnet, Christophe Champallou, Corine Veyret, Marc Debled
Publikováno v:
Journal of Pain and Symptom Management. 25:185-190
Bisphosphonates, such as pamidronate, are a new class of drugs, initially described for treatment of neoplasic hypercalcemia. Currently, they also may be used in the treatment of bone metastases from solid tumor, even without hypercalcemia. Hypocalce
Autor:
Christophe, Champallou, Jean Pierre, Basuyau, Corine, Veyret, Paule, Chinet, Marc, Debled, Annie, Chevrier, Marie Hélène, Grongnet, Philippe, Brunelle
Publikováno v:
Journal of pain and symptom management. 25(2)
Bisphosphonates, such as pamidronate, are a new class of drugs, initially described for treatment of neoplasic hypercalcemia. Currently, they also may be used in the treatment of bone metastases from solid tumor, even without hypercalcemia. Hypocalce